News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–10
Matches
10
Sources here
7
Companies here
1
Search results Stored financial headlines

Active search

10 matching headlines

Ticker or company: SLSNMain company stories
Clear
Latest

Stock Titan Earnings

Solésence, Inc. (SLSN) flags inventory costing error and delays Q2 2026 10-Q filing

Solésence, Inc. (SLSN) announced a delay in filing its Q2 2026 Form 10-Q due to the discovery of an improper inventory costing methodology. The company is currently determining the necessary corrective measures and the financial impact of this error. Solésence expects to file the report within the Rule 12b-25 extension period, though it cautioned that additional information might …

Main company 🇺🇸 United States
Read at Stock Titan
Sharemaestro market context Price below Trend Line 52 weeks -72.8% SLSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
TradingKey Market update Main company 🇺🇸 United States

SLSN|Solesence Ord Shs|Price:0.940|Chg%:-0.055

This article provides detailed real-time quotes, market trends, and analysis for Solesence Ord Shs (SLSN). It includes key financial figures, performance metrics over various periods, technical indicators, and a shareholder breakdown. The page also presents frequently asked questions about the company's stock.

SLSN main company
Sharemaestro market context Price below Trend Line 52 weeks -72.8% SLSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Earnings Main company 🇺🇸 United States

Solesence Ord Shs (SLSN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Solesence Ord Shs (SLSN), detailing its current stock performance, market capitalization, and P/E ratio. It highlights an "Earnings Forecast" section within TradingKey's analysis tools for the company, suggesting an outlook on future EPS, revenue, Net Profit, and …

SLSN main company
Sharemaestro market context Price below Trend Line 52 weeks -72.8% SLSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Solésence will report its second-quarter results before markets open Aug. 11

Solésence (Nasdaq: SLSN) announced it will report its second-quarter 2026 financial results before the market opens on Tuesday, August 11, 2026. The company will also host a conference call and webcast on the same day at 7:30 a.m. CT / 8:30 a.m. ET, featuring …

SLSN main company
Sharemaestro market context Price below Trend Line 52 weeks -72.8% SLSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingView Earnings Main company 🇺🇸 United States

Solesence, Inc. Revenue Breakdown – NASDAQ:SLSN

The article provides a revenue breakdown for Solesence, Inc. (NASDAQ: SLSN), highlighting its financial performance. The primary source of revenue is identified as the United States, contributing $56.90 million USD last year and $50.52 million USD the year prior.

SLSN main company
Sharemaestro market context Price below Trend Line 52 weeks -72.8% SLSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
The Globe and Mail Market update Main company 🇺🇸 United States

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solesence, Inc. (SLSN) has introduced two new scalp care products, a Revitalizing Scalp Serum and a Scalp Screen Dry Shampoo SPF 45+ Sunscreen, utilizing its patented WHSPR and Kleair technologies. These launches aim to expand the company's consumer product portfolio and capitalize on the …

SLSN main company
Sharemaestro market context Price below Trend Line 52 weeks -72.8% SLSN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context